A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Clinical trial NCT01299480 · COMPLETED

Trial details

NCT number: NCT01299480
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Vaccine

Start date: 2011-03-03
Primary completion: 2012-05-03
Enrollment: 1714

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.